.START 

Cooper Cos. reported a net loss for the fiscal third quarter, ended July 31, of $11.8 million, sharply narrower than the year-earlier loss of $61 million. 

Cooper has been involved in a lengthy process of selling assets that has been complicated in recent months by a dissident shareholder group's battle to win control of the company. 

The latest period's results comprise an operating loss of $6.4 million and a $5.4 million charge related to debt restructuring.
In the year-earlier quarter, the maker of health-care products had an operating loss of $53.1 million, $4.6 million of charges related to debt restructuring and a $3.3 million loss from discontinued operations.
Sales for the latest period totaled $10.7 million, a 62% slide from $28.4 million last year. 

For the nine months, Cooper had a net loss of $49.8 million, comprising an operating loss of $21.3 million, a $21.2 million loss from discontinued operations and $7.3 milion of charges from debt restructuring.
In the year-earlier nine months, the company had a net loss of $92.4 million, composed of an operating loss of $82.3 million and a $10 million loss from discontinued operations. 

In composite trading on the New York Stock Exchange, Cooper closed at $3, unchanged. 

